Union health minister Mansukh Mandaviya has said that a decision on booster dose would be taken based on the expert recommendation only. He said that the present aim is to vaccinate the whole population with both doses...
Hyderabad based Bharat Biotech’s Covaxin has been found 65.2 per cent effective against Delta variant. Indian covid vaccine Covaxin’s phase III data has been reviewed and published in the medical journal The...
Studies have shown that a mechanical thrombectomy is an effective tool for stroke management even in patients above 80 years of ages. Stroke is a medical condition in which blood supply to the brain is affected depriving the...
A total of 11,04,55,016 people above the age of 60 years have been administered with the first dose of Covid-19 vaccine so far in the country, the Union Health Ministry on Saturday said. However, only 6,78,27,591 people in...
The ongoing Covid pandemic have an airborne transmission and the particulate matter (PM) in the air could act as a carrier to increase the spread of the Covid virus like others. Dr Abhishek Shankar, Associate Professor,...
By Abhishek Shankar, Pritanjali Singh Globally, cancer has emerged as an important contributor to human health and burden is growing with each passing year. Cancer has emerged as an important health issue in last few...
Neurologists from all parts of Indian come under one roof to deliberate on making neurosurgery safer for patients The Department of neurosurgery, Max Super Specialty Hospital, Vaishali organized Neruro-Con 2021. The...
The Health Minister Mansukh Mandaviya on Thursday morning visited the All India Institute of Medical Sciences to meet and enquire about the health condition of former PM Manmohan Singh. Former PM is admitted at AIIMS...
As the pandemic affected our lives, we changed and learnt to adapt to the limitations of a new world. We even turned limitations into new opportunities and ideas. One of which, is our move to the cyber world. When we could...
The World Health Organization will meet next week with an independent group of experts again to take final decision on whether to grant Emergency Use Listing to Covaxin. The WHO will carry out the risk and benefit assessment...
